Caribou Biosciences, Inc. (CRBU)
Biological Products, (No Diagnostic Substances)
Latest Price
$1.46
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.06
P/B Ratio
1.37
Institutional Ownership
35.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Pfizer Inc | 4.69M | $8.0M | 4.84% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.77M | $7.0M | 3.89% | -- | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 2.59M | $4.0M | 2.67% | +950.6K | 2026-03-31 |
| Kynam Capital Management, LP | 2.50M | $4.0M | 2.58% | -- | 2026-03-31 |
| BlackRock, Inc. | 2.14M | $4.0M | 2.21% | +2.1K | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 1.30M | $2.0M | 1.34% | +304.0K | 2026-03-31 |
| Aberdeen Group plc | 1.21M | $2.0M | 1.25% | -176.4K | 2026-03-31 |
| MARSHALL WACE, LLP | 1.21M | $2.0M | 1.24% | +324.6K | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 1.07M | $2.0M | 1.11% | +307.4K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.02M | $1.0M | 1.05% | +41.1K | 2026-03-31 |